Pericarditis as the Main Clinical Manifestation of COVID-19 in Adolescents
- PMID: 33847300
- DOI: 10.1097/INF.0000000000003096
Pericarditis as the Main Clinical Manifestation of COVID-19 in Adolescents
Abstract
Children and adolescents with severe acute respiratory syndrome coronavirus 2 infection usually have a milder illness, lower mortality rates and may manifest different clinical entities compared with adults. Acute effusive pericarditis is a rare clinical manifestation in patients with COVID-19, especially among those without concurrent pulmonary disease or myocardial injury. We present 2 cases of acute pericarditis, in the absence of initial respiratory or other symptoms, in adolescents with COVID-19.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19 - studies needed. N Engl J Med. 2020; 382:1194–1196.
-
- World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2020. Available at: https://covid19.who.int/. Accessed December 5, 2020.
-
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet. 2020; 395:497–506.
-
- Lu X, Zhang L, Du H, et al.; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in Children. N Engl J Med. 2020; 382:1663–1665.
-
- Adler Y, Charron P, Imazio M, et al.; ESC Scientific Document Group. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015; 36:2921–2964.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical